Purpose
To determine whether combined therapy with colestipol hydrochloride plus niacin will produce clinically significant changes in
coronary, carotid and femoral artery atherosclerosis, and coronary venous bypass grafts
References
Cashin-Hemphill L, Mack WJ, Pogoda JM, et al: Beneficial effects of colestipol-niacin on coronary atherosclerosis. A
4-year follow-up. JAMA 1990, 264:3013–3017.
|
Farmacêutica